ArticleInfection and immunity2004
Use of deoxyribose by intestinal and extraintestinal pathogenic Escherichia coli strains: a metabolic adaptation involved in competitiveness.
Article in Infection and immunity, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- If you eat it, or secrete it, they will grow: the expanding list of nutrients utilized by human gut bacteria.Journal of bacteriology · 2020Review
- Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.Clinical microbiology reviews · 2019Review
- Enzyme promiscuity shapes adaptation to novel growth substrates.Molecular systems biology · 2019Article
- Metagenomics-Based, Strain-Level Analysis ofFrontiers in microbiology · 2018Article
- Sequencing a piece of history: complete genome sequence of the originalMicrobial genomics · 2017Article
- Tracking Bioluminescent ETEC duringFrontiers in cellular and infection microbiology · 2017Article
- Article
- Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.Clinical microbiology reviews · 2014Review
- Catabolism of host-derived compounds during extracellular bacterial infections.Journal of cellular biochemistry · 2014Article
- Genome-scale metabolic reconstructions of multiple Escherichia coli strains highlight strain-specific adaptations to nutritional environments.Proceedings of the National Academy of Sciences of the United States of America · 2013Article
- Role of the vpe carbohydrate permease in Escherichia coli urovirulence and fitness in vivo.Infection and immunity · 2012Article
- The decoupling between genetic structure and metabolic phenotypes in Escherichia coli leads to continuous phenotypic diversity.Journal of evolutionary biology · 2011Article
- In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice.Applied and environmental microbiology · 2010Article
- Role of deoxyribose catabolism in colonization of the murine intestine by pathogenic Escherichia coli strains.Infection and immunity · 2009Article
- Loss of catabolic function in Streptococcus agalactiae strains and its association with neonatal meningitis.Journal of clinical microbiology · 2006Article
- How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains.Proceedings of the National Academy of Sciences of the United States of America · 2006Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We showed that the deoK operon, which confers the ability to use deoxyribose as a carbon source, is more common among pathogenic than commensal Escherichia coli strains. The expression of the deoK operon increases the competitiveness of clinical isolates, suggesting that this biochemical characteristic plays a role in host infectivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.